Ten companies boasted whopping gains on Tuesday despite a wider market pessimism, as a flurry of corporate developments, including impressive earnings and bullish outlooks, sparked buying appetite.
In contrast, Wall Street’s main indices all finished in the red territory. The Dow Jones was down by 0.27 percent, the S&P 500 dropped 0.39 percent, and the tech-heavy Nasdaq declined 0.38 percent.
In this article, we named the 10 best-performing stocks during the trading session and detailed the reasons behind their gains. To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million in trading volume.
10. Pony AI Inc. (NASDAQ: PONY)
Chinese firm Pony AI saw its share prices rise by 5.74 percent on Tuesday to close at $17.88 apiece as investors cheered its strong revenue performance in the first quarter of the year.
In its earnings release, Pony AI Inc. (NASDAQ: PONY) said revenues grew by 12 percent to $14 million from $12.5 million registered in the same period last year, thanks to a 200-percent jump in its Robotaxi services.
However, net loss remained higher by 79 percent to $37.4 million as compared with $20.8 million in the same period a year earlier, due to investments in the mass production of Generation 7 vehicles, coupled with one-time expenses related to its initial public offering that was only settled during the quarter, as well as higher employee compensation.
In recent news, Pony AI Inc. (NASDAQ: PONY) partnered with ride-hailing giant Uber Technologies Inc. (NYSE: UBER) to expand and offer its robotaxis in the Middle East through the Uber app.
The two companies also committed to deepening their partnership through expansion into other global markets.
9. Moderna, Inc. (NASDAQ:MRNA)
Moderna extended its winning streak for a third straight day on Tuesday, adding 6.06 percent to close at $27.99 apiece, following the Trump administration’s issuance of new guidelines for COVID-19 shots.
According to the Food and Drug Administration (FDA), they would continue to use a streamlined approach to make COVID-19 boosters available to adults aged 65 and older, as well as children and adults with at least one high-risk health problem.
Despite the limited use, the news provided a boost to vaccine makers, including Moderna, Inc. (NASDAQ:MRNA), which was among the companies that found success with its COVID-19 shots, as it meant that it could continue to sell vaccines to high-risk groups.
In other news, Moderna, Inc. (NASDAQ:MRNA) narrowed its net loss in the first quarter of the year by 17.4 percent to $971 million from the $1.17 billion in the same period last year.
Revenues declined by 35 percent to $108 million from $167 million in the same period last year due to lower vaccination rates, coupled with the continued normalization of COVID into a seasonal commercial market.
Looking ahead, Moderna, Inc. (NASDAQ:MRNA) said that it is targeting to book revenues between $1.5 billion and $2.5 billion.
8. Peloton Interactive, Inc. (NASDAQ:PTON)
Peloton Interactive saw its share price increase by 6.84 percent to close at $6.72 apiece, with investors appearing to be just trading sideways while waiting for fresh catalysts to further boost investing appetite.
Additionally, investment firm Macquarie’s upgraded rating on the stock may have helped buoy its share prices. Last week, the company boosted its rating for Peloton Interactive, Inc. (NASDAQ:PTON) to “outperform” from “neutral” previously following its strong earnings performance for the third quarter of fiscal year 2025, coupled with an optimistic outlook.
During the period, Peloton Interactive, Inc. (NASDAQ:PTON) narrowed its net loss by 72 percent to $47.7 million from $167.3 million in the same period last year. Revenues, on the other hand, dropped by 13 percent to $624 million from $717.7 million year-on-year.
For the full year, Peloton Interactive, Inc. (NASDAQ:PTON) had raised its midpoint guidance for revenues by $7.5 million to a range of $2.455 billion to $2.47 billion on expectations of higher subscription revenues.
7. Vodafone Group Public Limited Company (NASDAQ:VOD)
Vodafone extended its winning streak for a fourth consecutive day on Tuesday, adding 7.78 percent to close at $10.39 apiece following the commencement of the company’s new 2-billion euro buyback program.
In its latest earnings release, Vodafone Group Public Limited Company (NASDAQ:VOD) announced the commencement of a new 2-billion euro buyback program, with the first tranche amounting to 500 million euros and commencing on Tuesday. This followed the first 2-billion euro share repurchase program, which concluded on Monday, May 19. Total dividends halve to 4.5 eurocents as compared with the 9 eurocents in 2024.
In the first quarter of the year, Vodafone Group Public Limited Company (NASDAQ:VOD) swung to a net loss of 3.7 billion euros from a net income of 1.57 billion euros in 2024.
Revenues, however, grew 2 percent to 37.4 billion euros from 36.7 billion euros year-on-year.
6. Lucid Group, Inc. (NASDAQ:LCID)
Lucid Group saw its share prices jump by 10.45 percent on Tuesday to close at $2.96 apiece, as penny traders appeared to have taken advantage of the previous day’s drop to buy shares at a low price.
Based on its historical share price data, the company traded sideways amid the lack of catalysts to further propel buying.
In recent news, Lucid Group, Inc. (NASDAQ:LCID) reported that its net loss attributable to shareholders grew by 6.9 percent to $731 million from the $684 million registered in the same period last year.
Revenues, however, increased by 36 percent to $235 million from $172 million year-on-year.
Looking ahead, Lucid Group, Inc. (NASDAQ:LCID) is looking to ramp up vehicle production to 20,000 units per year, more than double the 9,000 units delivered last year.
In the first quarter alone, Lucid Group Inc. (NASDAQ:LCID) delivered 3,109 units, translating to $235 million in sales.
5. Sibanye Stillwater Limited (NYSE:SBSW)
Sibanye Stillwater rallied for a fourth straight day on Tuesday, adding 14.46 percent to finish at $5.54 apiece, as investors continued to digest the company’s earnings performance and optimistic outlook for its business.
In a statement, Sibanye Stillwater Limited (NYSE:SBSW) CEO Neal Froneman said that he expects the company to continue posting positive outcomes from its actions over the past two years.
In the first quarter of the year, Sibanye Stillwater Limited (NYSE:SBSW) registered an 89-percent jump in adjusted EBITDA of $222 million as a result of its diversification and restructuring program. Among its businesses, PGM operations was the strongest, contributing $137 million.
“The increase in Group adjusted EBITDA for Q1 2025 was not solely a function of our leveraged exposure to the increasing gold price, but reflects the combined outcome of operational restructuring we implemented from H2 2023, which has resulted in increased profitability from most of our operations,” he said.
“Along with reduced future annual capital requirements, we believe that this result signals a clear inflection point for the Group, and is set to position us to realize ongoing value for stakeholders,” he added.
4. Warby Parker Inc. (WRBY)
Warby Parker Inc. saw its share prices surge by 15.63 percent on Tuesday to close at $20.34 apiece as investor sentiment was buoyed by news that it secured a $75-million investment from technology giant Google, in line with plans to jointly develop Artificial Intelligence-powered glasses.
In a statement, Warby Parker Inc. (WRBY) said that Google committed to investing the said amount in the company at its option, subject to reaching certain collaboration milestones. Additionally, it secured another $75 million to fund expenses needed for product development and commercialization.
Upon completion, Warby Parker Inc. (WRBY) said they intend to officially launch the smart glasses to the market after this year.
“We believe multimodal AI is perfectly suited for glasses, enabling real-time context and intelligence to augment a wearer’s surroundings as they move through the world. We couldn’t be more excited to be partnering with Google to bring together the best of AI and the best of eyewear,” said Warby Parker Inc. (WRBY) co-founder and co-CEO Dave Gilboa.
3. Amer Sports, Inc. (NYSE:AS)
Amer Sports saw its share prices increase by 19.05 percent on Tuesday to close at $37.37 apiece following an impressive earnings performance in the first quarter of the year.
In a statement, Amer Sports, Inc. (NYSE:AS) said revenues increased by 23 percent to $1.47 billion from $1.19 billion in the same period last year.
Net income, on the other hand, skyrocketed by 1,901 percent to $138.1 million from only $6.9 million in the same comparable period. Earnings per share ended at 24 cents, versus only 1 cent year-on-year.
Amer Sports, Inc. (NYSE:AS) said it is targeting to grow its revenues by 15 to 17 percent and fully diluted EPS between 67 and 72 cents during the full-year period, assuming US import tariffs on China remain at 30 percent, and the rest of the world at 10 percent.
Meanwhile, second quarter revenue growth is pegged at 16 to 18 percent, with fully diluted EPS at 2 cents.
2. Akero Therapeutics, Inc. (NASDAQ:AKRO)
Akero Therapeutics snapped a two-day losing streak on Tuesday, jumping 24.72 percent to close at $47.57 apiece as investors gobbled up shares following news that it was exploring a sale.
According to a report by StreetInsider, Akero Therapeutics, Inc. (NASDAQ:AKRO) is now in talks with an investment bank to assist with the process. However, it added that the company’s early interest and strategic review might not necessarily translate to a sale.
In its latest earnings release, Akero Therapeutics, Inc. (NASDAQ:AKRO) widened its net loss by 32.6 percent to $70.7 million from $53.3 million in the same period last year.
Operating expenses surged by 34.9 percent to $80.88 million from $59.95 million year-on-year. Net loss per common share was at 90 cents, similar to the same period a year ago.
Akero Therapeutics, Inc. (NASDAQ:AKRO) is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH).
1. D-Wave Quantum Inc. (NYSE:QBTS)
D-Wave Quantum surged by 25.93 percent on Tuesday to finish at $16.56 apiece following the launch of a new quantum computer, which is said to be capable of solving problems beyond the capabilities of a classical GPU-based supercomputer.
Called the Advantage2, it is said to be capable of addressing real-world use cases in areas such as optimization, materials simulation, and artificial intelligence (AI).
“Today marks a significant milestone not just for D-Wave, but for the quantum computing industry as a whole, as we bring to market our sixth-generation quantum computer, a system so powerful that it can solve hard problems outside the reach of one of the world’s largest exascale GPU-based classical supercomputers,” said D-Wave Quantum Inc. (NYSE:QBTS) CEO Alan Baratz.
Following the launch, customers are now able to access the Advantage2 system through the company’s LeapTM real-time quantum cloud service, which is available in more than 40 countries and offers 99.9 percent availability and uptime, sub-second response times, and SOC 2 Type 2 compliance to meet enterprise needs and security requirements.
While we acknowledge the potential of QBTS as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than QBTS but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
